Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). (Q53540821)
scientific article
Language:
Current Data About Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
(P31) (Q13442814)
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

(P304) 493-510
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

(P407) (Q1860)

(P433) 5
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

(P478) 20
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

(P577) Friday, October 1, 1999
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

(P921) (Q1129105)
(P887)

(P1433) (Q5164971)
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

(P1476) "Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II)." (language: en)
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

(P2093) Freedman BI
(P1545) 1
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

Wuerth JP
(P1545) 2
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

Cartwright K
(P1545) 3
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

Bain RP
(P1545) 4
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

Dippe S
(P1545) 5
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

Hershon K
(P1545) 6
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

Mooradian AD
(P1545) 7
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

Spinowitz BS
(P1545) 8
(P248)
(P698) 10503809
(P813) Tuesday, May 15, 2018
(P854) http://europepmc.org/abstract/MED/10503809

(P2860) (Q39738190)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q39714963)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q40186568)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q34049428)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q44031994)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q28324348)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q34980687)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q34352122)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q47436332)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q70513402)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q29615603)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q53846526)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q57491972)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q47205739)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q71769802)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q26778425)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q68666594)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q68698040)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q28279619)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q52618740)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q30922892)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q52865798)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

(Q28248823)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0197-2456%2899%2900024-0
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article

External Links
(P356) 10.1016/S0197-2456(99)00024-0
(P698) 10503809